0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OTC Gastrointestinal Products Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-0E10859
Home | Market Reports | Health| Pharmacy
Global and United States OTC Gastrointestinal Products Market Report Forecast 2022 2028
BUY CHAPTERS

Global OTC Gastrointestinal Products Market Research Report 2025

Code: QYRE-Auto-0E10859
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

OTC Gastrointestinal Products Market Size

The global market for OTC Gastrointestinal Products was valued at US$ 6488 million in the year 2024 and is projected to reach a revised size of US$ 9328 million by 2031, growing at a CAGR of 5.4% during the forecast period.

OTC Gastrointestinal Products Market

OTC Gastrointestinal Products Market

OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.
North American market for OTC Gastrointestinal Products is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for OTC Gastrointestinal Products is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of OTC Gastrointestinal Products include GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer, Bristol-Myers Squibb, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for OTC Gastrointestinal Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Gastrointestinal Products.
The OTC Gastrointestinal Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Gastrointestinal Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Gastrointestinal Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of OTC Gastrointestinal Products Market Report

Report Metric Details
Report Name OTC Gastrointestinal Products Market
Accounted market size in year US$ 6488 million
Forecasted market size in 2031 US$ 9328 million
CAGR 5.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • H2 Receptor Antagonists
  • Proton Pump Inhibitors (PPIs)
Segment by Application
  • Hospital Pharmacies
  • Drug Stores
  • Retail Stores
  • E-Commerce
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer, Bristol-Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of OTC Gastrointestinal Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of OTC Gastrointestinal Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is OTC Gastrointestinal Products Market growing?

Ans: The OTC Gastrointestinal Products Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the OTC Gastrointestinal Products Market size in 2031?

Ans: The OTC Gastrointestinal Products Market size in 2031 will be US$ 9328 million.

Who are the main players in the OTC Gastrointestinal Products Market report?

Ans: The main players in the OTC Gastrointestinal Products Market are GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer, Bristol-Myers Squibb

What are the Application segmentation covered in the OTC Gastrointestinal Products Market report?

Ans: The Applications covered in the OTC Gastrointestinal Products Market report are Hospital Pharmacies, Drug Stores, Retail Stores, E-Commerce

What are the Type segmentation covered in the OTC Gastrointestinal Products Market report?

Ans: The Types covered in the OTC Gastrointestinal Products Market report are H2 Receptor Antagonists, Proton Pump Inhibitors (PPIs)

1 OTC Gastrointestinal Products Market Overview
1.1 Product Definition
1.2 OTC Gastrointestinal Products by Type
1.2.1 Global OTC Gastrointestinal Products Market Value Comparison by Type (2024 VS 2031)
1.2.2 H2 Receptor Antagonists
1.2.3 Proton Pump Inhibitors (PPIs)
1.3 OTC Gastrointestinal Products by Application
1.3.1 Global OTC Gastrointestinal Products Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Global OTC Gastrointestinal Products Market Size Estimates and Forecasts
1.4.1 Global OTC Gastrointestinal Products Revenue 2020-2031
1.4.2 Global OTC Gastrointestinal Products Sales 2020-2031
1.4.3 Global OTC Gastrointestinal Products Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 OTC Gastrointestinal Products Market Competition by Manufacturers
2.1 Global OTC Gastrointestinal Products Sales Market Share by Manufacturers (2020-2025)
2.2 Global OTC Gastrointestinal Products Revenue Market Share by Manufacturers (2020-2025)
2.3 Global OTC Gastrointestinal Products Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of OTC Gastrointestinal Products, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Gastrointestinal Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Gastrointestinal Products, Product Type & Application
2.7 Global Key Manufacturers of OTC Gastrointestinal Products, Date of Enter into This Industry
2.8 Global OTC Gastrointestinal Products Market Competitive Situation and Trends
2.8.1 Global OTC Gastrointestinal Products Market Concentration Rate
2.8.2 The Global 5 and 10 Largest OTC Gastrointestinal Products Players Market Share by Revenue
2.8.3 Global OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OTC Gastrointestinal Products Market Scenario by Region
3.1 Global OTC Gastrointestinal Products Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global OTC Gastrointestinal Products Sales by Region: 2020-2031
3.2.1 Global OTC Gastrointestinal Products Sales by Region: 2020-2025
3.2.2 Global OTC Gastrointestinal Products Sales by Region: 2026-2031
3.3 Global OTC Gastrointestinal Products Revenue by Region: 2020-2031
3.3.1 Global OTC Gastrointestinal Products Revenue by Region: 2020-2025
3.3.2 Global OTC Gastrointestinal Products Revenue by Region: 2026-2031
3.4 North America OTC Gastrointestinal Products Market Facts & Figures by Country
3.4.1 North America OTC Gastrointestinal Products Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America OTC Gastrointestinal Products Sales by Country (2020-2031)
3.4.3 North America OTC Gastrointestinal Products Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe OTC Gastrointestinal Products Market Facts & Figures by Country
3.5.1 Europe OTC Gastrointestinal Products Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe OTC Gastrointestinal Products Sales by Country (2020-2031)
3.5.3 Europe OTC Gastrointestinal Products Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Region
3.6.1 Asia Pacific OTC Gastrointestinal Products Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific OTC Gastrointestinal Products Sales by Region (2020-2031)
3.6.3 Asia Pacific OTC Gastrointestinal Products Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America OTC Gastrointestinal Products Market Facts & Figures by Country
3.7.1 Latin America OTC Gastrointestinal Products Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America OTC Gastrointestinal Products Sales by Country (2020-2031)
3.7.3 Latin America OTC Gastrointestinal Products Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Gastrointestinal Products Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa OTC Gastrointestinal Products Sales by Country (2020-2031)
3.8.3 Middle East and Africa OTC Gastrointestinal Products Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global OTC Gastrointestinal Products Sales by Type (2020-2031)
4.1.1 Global OTC Gastrointestinal Products Sales by Type (2020-2025)
4.1.2 Global OTC Gastrointestinal Products Sales by Type (2026-2031)
4.1.3 Global OTC Gastrointestinal Products Sales Market Share by Type (2020-2031)
4.2 Global OTC Gastrointestinal Products Revenue by Type (2020-2031)
4.2.1 Global OTC Gastrointestinal Products Revenue by Type (2020-2025)
4.2.2 Global OTC Gastrointestinal Products Revenue by Type (2026-2031)
4.2.3 Global OTC Gastrointestinal Products Revenue Market Share by Type (2020-2031)
4.3 Global OTC Gastrointestinal Products Price by Type (2020-2031)
5 Segment by Application
5.1 Global OTC Gastrointestinal Products Sales by Application (2020-2031)
5.1.1 Global OTC Gastrointestinal Products Sales by Application (2020-2025)
5.1.2 Global OTC Gastrointestinal Products Sales by Application (2026-2031)
5.1.3 Global OTC Gastrointestinal Products Sales Market Share by Application (2020-2031)
5.2 Global OTC Gastrointestinal Products Revenue by Application (2020-2031)
5.2.1 Global OTC Gastrointestinal Products Revenue by Application (2020-2025)
5.2.2 Global OTC Gastrointestinal Products Revenue by Application (2026-2031)
5.2.3 Global OTC Gastrointestinal Products Revenue Market Share by Application (2020-2031)
5.3 Global OTC Gastrointestinal Products Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline OTC Gastrointestinal Products Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck OTC Gastrointestinal Products Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis OTC Gastrointestinal Products Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer OTC Gastrointestinal Products Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer OTC Gastrointestinal Products Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Company Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Gastrointestinal Products Industry Chain Analysis
7.2 OTC Gastrointestinal Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Gastrointestinal Products Production Mode & Process Analysis
7.4 OTC Gastrointestinal Products Sales and Marketing
7.4.1 OTC Gastrointestinal Products Sales Channels
7.4.2 OTC Gastrointestinal Products Distributors
7.5 OTC Gastrointestinal Products Customer Analysis
8 OTC Gastrointestinal Products Market Dynamics
8.1 OTC Gastrointestinal Products Industry Trends
8.2 OTC Gastrointestinal Products Market Drivers
8.3 OTC Gastrointestinal Products Market Challenges
8.4 OTC Gastrointestinal Products Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global OTC Gastrointestinal Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global OTC Gastrointestinal Products Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global OTC Gastrointestinal Products Market Competitive Situation by Manufacturers in 2024
 Table 4. Global OTC Gastrointestinal Products Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global OTC Gastrointestinal Products Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global OTC Gastrointestinal Products Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global OTC Gastrointestinal Products Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market OTC Gastrointestinal Products Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of OTC Gastrointestinal Products, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of OTC Gastrointestinal Products, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of OTC Gastrointestinal Products, Product Type & Application
 Table 12. Global Key Manufacturers of OTC Gastrointestinal Products, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global OTC Gastrointestinal Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Gastrointestinal Products as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global OTC Gastrointestinal Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global OTC Gastrointestinal Products Sales by Region (2020-2025) & (K Units)
 Table 18. Global OTC Gastrointestinal Products Sales Market Share by Region (2020-2025)
 Table 19. Global OTC Gastrointestinal Products Sales by Region (2026-2031) & (K Units)
 Table 20. Global OTC Gastrointestinal Products Sales Market Share by Region (2026-2031)
 Table 21. Global OTC Gastrointestinal Products Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global OTC Gastrointestinal Products Revenue Market Share by Region (2020-2025)
 Table 23. Global OTC Gastrointestinal Products Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global OTC Gastrointestinal Products Revenue Market Share by Region (2026-2031)
 Table 25. North America OTC Gastrointestinal Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America OTC Gastrointestinal Products Sales by Country (2020-2025) & (K Units)
 Table 27. North America OTC Gastrointestinal Products Sales by Country (2026-2031) & (K Units)
 Table 28. North America OTC Gastrointestinal Products Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America OTC Gastrointestinal Products Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe OTC Gastrointestinal Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe OTC Gastrointestinal Products Sales by Country (2020-2025) & (K Units)
 Table 32. Europe OTC Gastrointestinal Products Sales by Country (2026-2031) & (K Units)
 Table 33. Europe OTC Gastrointestinal Products Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe OTC Gastrointestinal Products Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific OTC Gastrointestinal Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific OTC Gastrointestinal Products Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific OTC Gastrointestinal Products Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific OTC Gastrointestinal Products Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific OTC Gastrointestinal Products Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America OTC Gastrointestinal Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America OTC Gastrointestinal Products Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America OTC Gastrointestinal Products Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America OTC Gastrointestinal Products Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America OTC Gastrointestinal Products Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa OTC Gastrointestinal Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa OTC Gastrointestinal Products Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa OTC Gastrointestinal Products Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa OTC Gastrointestinal Products Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa OTC Gastrointestinal Products Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global OTC Gastrointestinal Products Sales (K Units) by Type (2020-2025)
 Table 51. Global OTC Gastrointestinal Products Sales (K Units) by Type (2026-2031)
 Table 52. Global OTC Gastrointestinal Products Sales Market Share by Type (2020-2025)
 Table 53. Global OTC Gastrointestinal Products Sales Market Share by Type (2026-2031)
 Table 54. Global OTC Gastrointestinal Products Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global OTC Gastrointestinal Products Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global OTC Gastrointestinal Products Revenue Market Share by Type (2020-2025)
 Table 57. Global OTC Gastrointestinal Products Revenue Market Share by Type (2026-2031)
 Table 58. Global OTC Gastrointestinal Products Price (USD/Unit) by Type (2020-2025)
 Table 59. Global OTC Gastrointestinal Products Price (USD/Unit) by Type (2026-2031)
 Table 60. Global OTC Gastrointestinal Products Sales (K Units) by Application (2020-2025)
 Table 61. Global OTC Gastrointestinal Products Sales (K Units) by Application (2026-2031)
 Table 62. Global OTC Gastrointestinal Products Sales Market Share by Application (2020-2025)
 Table 63. Global OTC Gastrointestinal Products Sales Market Share by Application (2026-2031)
 Table 64. Global OTC Gastrointestinal Products Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global OTC Gastrointestinal Products Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global OTC Gastrointestinal Products Revenue Market Share by Application (2020-2025)
 Table 67. Global OTC Gastrointestinal Products Revenue Market Share by Application (2026-2031)
 Table 68. Global OTC Gastrointestinal Products Price (USD/Unit) by Application (2020-2025)
 Table 69. Global OTC Gastrointestinal Products Price (USD/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline OTC Gastrointestinal Products Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Merck OTC Gastrointestinal Products Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis OTC Gastrointestinal Products Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. Bayer Company Information
 Table 86. Bayer Description and Business Overview
 Table 87. Bayer OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer OTC Gastrointestinal Products Product
 Table 89. Bayer Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer OTC Gastrointestinal Products Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Bristol-Myers Squibb Company Information
 Table 96. Bristol-Myers Squibb Description and Business Overview
 Table 97. Bristol-Myers Squibb OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Bristol-Myers Squibb OTC Gastrointestinal Products Product
 Table 99. Bristol-Myers Squibb Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. OTC Gastrointestinal Products Distributors List
 Table 103. OTC Gastrointestinal Products Customers List
 Table 104. OTC Gastrointestinal Products Market Trends
 Table 105. OTC Gastrointestinal Products Market Drivers
 Table 106. OTC Gastrointestinal Products Market Challenges
 Table 107. OTC Gastrointestinal Products Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of OTC Gastrointestinal Products
 Figure 2. Global OTC Gastrointestinal Products Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global OTC Gastrointestinal Products Market Share by Type: 2024 & 2031
 Figure 4. H2 Receptor Antagonists Product Picture
 Figure 5. Proton Pump Inhibitors (PPIs) Product Picture
 Figure 6. Global OTC Gastrointestinal Products Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global OTC Gastrointestinal Products Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Drug Stores
 Figure 10. Retail Stores
 Figure 11. E-Commerce
 Figure 12. Global OTC Gastrointestinal Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global OTC Gastrointestinal Products Market Size (2020-2031) & (US$ Million)
 Figure 14. Global OTC Gastrointestinal Products Sales (2020-2031) & (K Units)
 Figure 15. Global OTC Gastrointestinal Products Average Price (USD/Unit) & (2020-2031)
 Figure 16. OTC Gastrointestinal Products Report Years Considered
 Figure 17. OTC Gastrointestinal Products Sales Share by Manufacturers in 2024
 Figure 18. Global OTC Gastrointestinal Products Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest OTC Gastrointestinal Products Players: Market Share by Revenue in OTC Gastrointestinal Products in 2024
 Figure 20. OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global OTC Gastrointestinal Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America OTC Gastrointestinal Products Sales Market Share by Country (2020-2031)
 Figure 23. North America OTC Gastrointestinal Products Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe OTC Gastrointestinal Products Sales Market Share by Country (2020-2031)
 Figure 27. Europe OTC Gastrointestinal Products Revenue Market Share by Country (2020-2031)
 Figure 28. Germany OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific OTC Gastrointestinal Products Revenue Market Share by Region (2020-2031)
 Figure 35. China OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America OTC Gastrointestinal Products Sales Market Share by Country (2020-2031)
 Figure 46. Latin America OTC Gastrointestinal Products Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa OTC Gastrointestinal Products Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E OTC Gastrointestinal Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of OTC Gastrointestinal Products by Type (2020-2031)
 Figure 56. Global Revenue Market Share of OTC Gastrointestinal Products by Type (2020-2031)
 Figure 57. Global OTC Gastrointestinal Products Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of OTC Gastrointestinal Products by Application (2020-2031)
 Figure 59. Global Revenue Market Share of OTC Gastrointestinal Products by Application (2020-2031)
 Figure 60. Global OTC Gastrointestinal Products Price (USD/Unit) by Application (2020-2031)
 Figure 61. OTC Gastrointestinal Products Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart